Interim report Q2 2018 is now available

Jon Sigurdsson, President & CEO, comments:

“After a slow start of the year, the second quarter came in as expected with strong sales and profitability. Our high-end innovative products performed well in both business segments, which include lower- and upper-extremity bionics in prosthetics and our osteoarthritis solutions in bracing and supports.“

Please visit our IR-section for further information.

About Össur

Pioneers of advanced technology, our mission is to improve people’s mobility. As a global leader in non-invasive orthopaedics, we have nurtured an innovative mind-set, continuously pushing the boundaries to create the best products and services in the fields of Prosthetic, Osteoarthritis and Injury Solutions.

True advocates of "Life Without Limitations", we work with individuals, clinicians and diverse communities around the world to support a better quality of life for millions of people.

More about Össur

Latest Quote

Volume:
Low: High:

Investor Relations

We serve our investors, by communicating in an informative and honest way. We are ambitious about the way we interact. It is our policy to provide investors, analysts and other stakeholders with comprehensive and accurate information to improve the understanding of the current and expected development of Össur.

Visit our Investor Information page